Cargando…
Construction of a risk signature for adrenocortical carcinoma using immune-related genes
BACKGROUND: Adrenocortical carcinoma (ACC) is considered a rare tumor with a dismal prognosis. Expression of immune-related genes (IRGs) in ACC and correlations between IRGs and ACC prognosis were assessed using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. METHODS:...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658150/ https://www.ncbi.nlm.nih.gov/pubmed/33209656 http://dx.doi.org/10.21037/tau-20-485 |
_version_ | 1783608605701832704 |
---|---|
author | Fu, Yang Sun, Shanshan Bi, Jianbin Kong, Chuize |
author_facet | Fu, Yang Sun, Shanshan Bi, Jianbin Kong, Chuize |
author_sort | Fu, Yang |
collection | PubMed |
description | BACKGROUND: Adrenocortical carcinoma (ACC) is considered a rare tumor with a dismal prognosis. Expression of immune-related genes (IRGs) in ACC and correlations between IRGs and ACC prognosis were assessed using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. METHODS: To preliminarily predict immune cell infiltration, an immune score was calculated using ESTIMATE. Differentially expressed IRGs were screened, and potential biological functions were investigated. We then performed univariate Cox regression to identify IRGs associated with survival, and the regulatory mechanisms of IRGs associated with survival were predicted. We built a risk signature through multivariate Cox regression to evaluate patient overall survival (OS). RESULTS: A high immune score predicted a good prognosis and an early clinical stage in ACC. We identified 30 IRGs associated with survival and then predicted associated regulatory mechanisms via protein-protein interaction (PPI) and transcription factor (TF) regulatory networks. The risk signature established by multivariate Cox regression correlated significantly with prognosis in ACC. CONCLUSIONS: The vital roles of IRGs in ACC were assessed, and the risk signature obtained based on IRGs associated with survival independently predicted ACC prognosis. |
format | Online Article Text |
id | pubmed-7658150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-76581502020-11-17 Construction of a risk signature for adrenocortical carcinoma using immune-related genes Fu, Yang Sun, Shanshan Bi, Jianbin Kong, Chuize Transl Androl Urol Original Article BACKGROUND: Adrenocortical carcinoma (ACC) is considered a rare tumor with a dismal prognosis. Expression of immune-related genes (IRGs) in ACC and correlations between IRGs and ACC prognosis were assessed using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. METHODS: To preliminarily predict immune cell infiltration, an immune score was calculated using ESTIMATE. Differentially expressed IRGs were screened, and potential biological functions were investigated. We then performed univariate Cox regression to identify IRGs associated with survival, and the regulatory mechanisms of IRGs associated with survival were predicted. We built a risk signature through multivariate Cox regression to evaluate patient overall survival (OS). RESULTS: A high immune score predicted a good prognosis and an early clinical stage in ACC. We identified 30 IRGs associated with survival and then predicted associated regulatory mechanisms via protein-protein interaction (PPI) and transcription factor (TF) regulatory networks. The risk signature established by multivariate Cox regression correlated significantly with prognosis in ACC. CONCLUSIONS: The vital roles of IRGs in ACC were assessed, and the risk signature obtained based on IRGs associated with survival independently predicted ACC prognosis. AME Publishing Company 2020-10 /pmc/articles/PMC7658150/ /pubmed/33209656 http://dx.doi.org/10.21037/tau-20-485 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Fu, Yang Sun, Shanshan Bi, Jianbin Kong, Chuize Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title | Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title_full | Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title_fullStr | Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title_full_unstemmed | Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title_short | Construction of a risk signature for adrenocortical carcinoma using immune-related genes |
title_sort | construction of a risk signature for adrenocortical carcinoma using immune-related genes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658150/ https://www.ncbi.nlm.nih.gov/pubmed/33209656 http://dx.doi.org/10.21037/tau-20-485 |
work_keys_str_mv | AT fuyang constructionofarisksignatureforadrenocorticalcarcinomausingimmunerelatedgenes AT sunshanshan constructionofarisksignatureforadrenocorticalcarcinomausingimmunerelatedgenes AT bijianbin constructionofarisksignatureforadrenocorticalcarcinomausingimmunerelatedgenes AT kongchuize constructionofarisksignatureforadrenocorticalcarcinomausingimmunerelatedgenes |